Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00163566 · ClinicalTrials.gov registry record · Phase 2
Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80
A Phase 2 study, sponsored by ASCEND Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 128
- Enrollment target
NCT00163566 is a Phase 2 study that has completed, run by ASCEND Therapeutics. The registered enrollment target is 128 participants.
The verdict
NCT00163566, a Phase 2 study, has completed, sponsored by ASCEND Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 128 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether DHT-Gel, when applied daily to the skin, can relieve the symptoms of low testosterone in men aged 55-80. These symptoms include reduced muscle strength, increase fat mass, low libido, feeling blue or moody
Interventions
- DRUG Dihydrotestosterone (0.7%) in hydroalcoholic gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-09-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00163566
The ClinicalTrials.gov registry entry for NCT00163566 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ASCEND Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dihydrotestosterone (0.7%) in hydroalcoholic gel is the first listed.
NCT00163566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00163566 about?
NCT00163566 is a clinical study titled "Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80". The purpose of this study is to evaluate whether DHT-Gel, when applied daily to the skin, can relieve the symptoms of low testosterone in men aged 55-80. These symptoms include reduced muscle strength, increase fat mass, low libido, feeling blue or moody
What is the current status of trial NCT00163566?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 128 participants. The study started on 2004-10. Estimated completion is 2006-09-25.
What interventions are being tested in trial NCT00163566?
The interventions under investigation include: Dihydrotestosterone (0.7%) in hydroalcoholic gel (DRUG).
Who is sponsoring clinical trial NCT00163566?
This trial is sponsored by ASCEND Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.